Bipradeb Singha Selected Research

BAY 11-7085

1/2017	Histone Deacetylase (HDAC) Inhibition Induces IκB Kinase (IKK)-dependent Interleukin-8/CXCL8 Expression in Ovarian Cancer Cells.
9/2015	IKK inhibition increases bortezomib effectiveness in ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bipradeb Singha Research Topics

Disease

7	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 01/2014
7	Neoplasms (Cancer) 10/2018 - 01/2014
5	Neoplasm Metastasis (Metastasis) 05/2020 - 01/2014
3	Ovarian Epithelial Carcinoma 05/2020 - 01/2017
3	Hematologic Neoplasms (Hematological Malignancy) 01/2017 - 01/2014
2	Multiple Myeloma 01/2014 - 01/2014
1	Inflammation (Inflammations) 01/2014
1	Prostatic Neoplasms (Prostate Cancer) 09/2013

Drug/Important Bio-Agent (IBA)

6	Interleukin-8 (Interleukin 8)IBA 01/2017 - 09/2013
5	ChemokinesIBA 01/2017 - 09/2013
5	Bortezomib (Velcade)FDA Link 09/2015 - 09/2013
4	Phosphotransferases (Kinase)IBA 01/2020 - 01/2014
3	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2014 - 09/2013
2	Messenger RNA (mRNA)IBA 01/2020 - 01/2014
2	BAY 11-7085IBA 01/2017 - 09/2015
2	Pharmaceutical PreparationsIBA 01/2017 - 09/2015
2	CytokinesIBA 01/2014 - 01/2014
1	SuspensionsIBA 05/2020
1	Indicators and Reagents (Reagents)IBA 10/2018
1	Biomarkers (Surrogate Marker)IBA 10/2018
1	Proteins (Proteins, Gene)FDA Link 10/2018
1	Complement System Proteins (Complement)IBA 10/2018
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2017
1	Histone Deacetylase InhibitorsIBA 01/2017
1	Vorinostat FDA Link 01/2017
1	AntigensIBA 01/2017
1	Early Growth Response Protein 1IBA 01/2014
1	Proteasome InhibitorsIBA 01/2014
1	Interleukin-6 (Interleukin 6)IBA 01/2014
1	Chemotactic FactorsIBA 01/2014
1	HMGB1 Protein (HMG1)IBA 01/2014
1	AndrogensIBA 09/2013

Therapy/Procedure

1	Therapeutics 01/2014